Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device
- PMID: 3098498
- DOI: 10.1016/0010-7824(86)90007-7
Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device
Abstract
Following use of either the Levonorgestrel 20 mcg/day or the TCu 380 Ag IUD in a randomized comparative study, 110 women stopped contracepting to have planned pregnancies. Pregnancy rates and recovery of fertility have been assessed. Age at acceptance, duration of use, parity and intervals between last pregnancy and IUD insertion or removal were similar for both groups. Life table pregnancy rates at one year were higher than 90 per cent for both device groups; but because some women quickly changed their minds or had been at risk of pregnancy only a short time before the analysis date, only 60.9 percent had actually become pregnant. Median time to planned pregnancy was 3 months for the TCu 380 Ag group and 4 months for the Levonorgestrel 20 group. Neither duration of use nor age at insertion or age at termination affected the pregnancy rates significantly.
PIP: Following use of either the Levonorgestrel 20 mcg/day or the TCu 380 Ag IUD in a randomized comparative study, 110 women stopped contracepting to have planned pregnancies. Pregnancy rates and recovery of fertility have been assessed. Age at acceptance, duration of use, parity and intervals between last pregnancy and IUD insertion or removal were similar for both groups. Life table pregnancy rates at 1 year were higher than 90% for both device groups; but because some women quickly changed their minds or had been at risk of pregnancy only a short time before the analysis date, only 60.9% had actually become pregnant. Median time to planned pregnancy was 3 months for the TCu 380 Ag group and 4 months for the Levonorgestrel 20 group. Neither duration of use nor age at inserttion or age at termination affected the pregnancy rates significantly.
Similar articles
-
Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.Am J Obstet Gynecol. 1992 Apr;166(4):1208-13. doi: 10.1016/s0002-9378(11)90607-3. Am J Obstet Gynecol. 1992. PMID: 1566771
-
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.Contraception. 1987 Mar;35(3):245-55. doi: 10.1016/0010-7824(87)90026-6. Contraception. 1987. PMID: 3111785 Clinical Trial.
-
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.Contraception. 1990 Oct;42(4):361-78. doi: 10.1016/0010-7824(90)90046-x. Contraception. 1990. PMID: 2124179 Clinical Trial.
-
An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t. Contraception. 1991. PMID: 1773615 Review.
-
Effectiveness of IUDs: a review.Contraception. 1987 Jul;36(1):55-84. doi: 10.1016/0010-7824(87)90061-8. Contraception. 1987. PMID: 3311626 Review.
Cited by
-
Return of fertility after discontinuation of contraception: a systematic review and meta-analysis.Contracept Reprod Med. 2018 Jul 23;3:9. doi: 10.1186/s40834-018-0064-y. eCollection 2018. Contracept Reprod Med. 2018. PMID: 30062044 Free PMC article. Review.
-
Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy.JAMA Neurol. 2018 Aug 1;75(8):962-969. doi: 10.1001/jamaneurol.2018.0646. JAMA Neurol. 2018. PMID: 29710218 Free PMC article.
-
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.Int J Womens Health. 2010 Aug 9;1:45-58. doi: 10.2147/ijwh.s4350. Int J Womens Health. 2010. PMID: 21072274 Free PMC article.
-
Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.Drug Saf. 2004;27(15):1185-204. doi: 10.2165/00002018-200427150-00003. Drug Saf. 2004. PMID: 15588115
-
Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.Cochrane Database Syst Rev. 2004;2004(3):CD001776. doi: 10.1002/14651858.CD001776.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266453 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources